Ulcerative Colitis Endoscopic Severity Scores
The two primary endoscopic scoring systems for ulcerative colitis are the Mayo Endoscopic Score (MES) and the Ulcerative Colitis Endoscopic Index of Severity (UCEIS), with UCEIS being the validated and more reliable option for clinical decision-making. 1
Mayo Endoscopic Score (MES)
The MES is a simple 4-point scale (0-3) that evaluates the most inflamed colonic segment 1:
- Grade 0: Normal or inactive disease
- Grade 1: Mild disease with erythema, decreased vascular pattern, mild friability
- Grade 2: Moderate disease with marked erythema, absent vascular pattern, moderate friability, erosions
- Grade 3: Severe disease with spontaneous bleeding and ulcerations
Clinical Significance of MES
Mucosal healing defined as MES 0 or 1 is associated with significantly lower colectomy rates, as demonstrated in the ACT-1 and ACT-2 infliximab trials where patients achieving MES 0-1 at week 8 had reduced colectomy rates beyond 54 weeks 1. This makes MES 0/1 the most commonly reported outcome in UC clinical trials 1.
Limitations of MES
The major weakness is lack of formal validation and variable interobserver agreement ranging from fair to high 1, 2. The assessment of friability is particularly subjective and inconsistent between observers 1, 2.
Ulcerative Colitis Endoscopic Index of Severity (UCEIS)
UCEIS is the only formally validated endoscopic score for UC and provides superior reliability 1. It is an 8-point composite score evaluating three parameters in the most severely affected colonic segment:
UCEIS Components
A. Vascular Pattern (0-2 points):
- 0 = Normal vascular pattern
- 1 = Patchy obliteration
- 2 = Complete obliteration
B. Bleeding (0-3 points):
- 0 = None
- 1 = Mucosal bleeding
- 2 = Luminal mild bleeding
- 3 = Luminal moderate to severe bleeding
C. Erosions and Ulcers (0-2 points):
- 0 = None
- 1 = Erosions
- 2 = Superficial ulcer
- 3 = Deep ulcer
Clinical Thresholds for UCEIS
A UCEIS score ≥4 is the validated cutoff for treatment escalation, demonstrating 80% sensitivity and 93% specificity for predicting need for intensified therapy 3. Endoscopic remission is defined as UCEIS = 0, while endoscopic response requires a decrease of ≥2 points 4.
Advantages of UCEIS
- Excellent interobserver and intraobserver agreement among experienced readers 1
- Excludes friability, eliminating the most subjective component of MES 1
- Superior correlation with clinical outcomes including treatment response and readmission rates compared to MES 5
- Strong correlation with histological activity (Pearson coefficient 0.723) 3
Limitations of UCEIS
The specific cutoffs for mild, moderate, and severe disease categories remain undefined 1. Additionally, it requires more familiarity and training compared to the simpler MES 2.
Comparative Performance
UCEIS consistently outperforms MES in predicting treatment escalation and 1-year readmission (AUC 0.88 and 0.75 respectively for UCEIS vs lower values for MES) 5. Both scores demonstrate similar correlation with patient-reported outcomes 2, but UCEIS provides more granular assessment with better reproducibility 1.
Other Scoring Systems
The Ulcerative Colitis Colonoscopic Index of Severity (UCCIS) is a recently validated 6-variable system that includes vascular pattern, granularity, ulceration, bleeding/friability, segmental assessment, and visual analog scale 2. It demonstrates good-to-excellent interobserver agreement but lacks defined cutoffs for remission and response 2.
Practical Recommendations
For clinical practice, use MES for simplicity and familiarity, but recognize its limitations in borderline cases (particularly distinguishing MES 1 vs 2). For clinical trials and when precise disease quantification is critical, UCEIS should be the preferred instrument given its validation and superior operating characteristics 1.
Common Pitfalls to Avoid
- Do not rely solely on friability assessment when using MES, as this has the poorest interobserver agreement 1, 2
- Evaluate the most severely affected segment, not an average of the entire colon 1
- Full colonoscopy may be necessary as up to 38% of patients have their most inflamed segment proximal to the sigmoid colon 6
- A UCEIS <4 does not automatically mean treatment should not be escalated; clinical context and symptoms must be integrated 3